Skip to main content
. Author manuscript; available in PMC: 2024 Apr 13.
Published in final edited form as: Toxicol Pathol. 2024 Jan 30;51(7-8):470–481. doi: 10.1177/01926233241227942

Table 1:

A summary of various modes of action (MOAs) for rodent hepatocarcinogenicity and their corresponding gene alterations in rodent studies

Hepatotoxicity in 2-week Toxicology Study
Hepatocarcinogenicity MOAs Potential target genes
Genotoxicity Ccng1, Lama5, Cdkn1a, Mdm2, Nhej.
Aryl hydrocarbon receptor (AhR) Cyp1a1, Cyp1b1, Cyp1a2
Constitutive Androstane Receptor/Pregnane X Receptor (CAR/PXR) Cyp2b1, Ces2c, Cyp3a23/3a1, Ugt2b1
Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) Acot1, Cyp4a1, Ehhadh, Cpt1b, Vnn1
Estrogen Receptor Rbp7, Cited4, Lifr, Orm1, Cyp4a8, Rgs3
Cytotoxicity Anxa2, Gpnmb, Tubb6, S100a10, Trib3
Oxidative Stress/Nrf2 Hmox1, Nqo1, Akr7a3, Srxn1, Gsta3
Inflammation Lcn2, A2m, Lbp, Tnfrsf21, Cxcl9